What will the medication actually cost me? It will cost whatever your pharmacy charges. At the manufacturers' own published self-pay prices as of September 2026, that figure runs from $149 a month to $449 a month depending on the drug and the dose. Your pharmacy bills it separately from the $299 membership fee. GoodLife Health sets nothing on the pharmacy transaction, sees nothing and takes nothing from it.
- Medication is billed by your pharmacy separately from the $299 membership fee.
- Published self-pay prices as of September 2026: Wegovy pens $199 then $349 a month, the Wegovy pill from $149, Zepbound vials $299 to $449.
- The membership fee never changes with your dose, your molecule or your refill count.
- Insurance coverage is never promised. Prior authorization belongs to your plan and your pharmacy.
The prices, dated and in the open
These are the manufacturers' own self-pay prices as published in September 2026 and we give them with the date because they change.
Through NovoCare, Wegovy pens are $199 a month for the first two fills on an introductory offer for new patients through December 2026 and $349 a month after that. The Wegovy pill starts from $149 a month at lower doses. Through LillyDirect, Zepbound vials run $299 to $449 a month depending on the dose. Those are the prices the manufacturers publish for cash-pay patients and they are the same for us as for any other practice, because the prescription goes to your pharmacy and the pharmacy's price is the pharmacy's business.
What we control is everything around that number. There is no program fee that rises when your dose rises. There is no molecule upcharge that makes Zepbound cost more through us. There is no membership tier that gates the stronger pens behind a higher plan. The fee for the doctor is $299 a month and the price of the medicine is the pharmacy's price and the two never touch.
Why the fee and the drug are separate
The unbundled structure is the whole point of the model. Some platforms bundle the drug and the care into one monthly price. Our fee is separate from the drug and does not rise with the dose.
We call our version Medication-Neutral Pricing. The membership fee covers the clinicians and four cardiometabolic lab panels a year. The pharmacy pays itself when you fill a prescription. If your clinician lowers your dose, our revenue does not move. If your protocol ends and no prescription is indicated, our revenue does not move either. That neutrality is what makes the advice trustworthy and it is also why we can publish the manufacturers' prices without hedging. We have no markup to protect.
The Biomarker Audit is the clinical half of the value. It covers Apolipoprotein B (ApoB), Lipoprotein (A), Hs-CRP, Hemoglobin A1c (HbA1c), Lipid Panel, Standard, Fasting Insulin, TSH With Reflex To Free T4 and more, every 90 days. In the definitive guide to Cardiometabolic Optimization we explain why those markers and not a scale alone, are what a prescribing decision should rest on.
What insurance will and will not do
We are never going to promise that insurance covers a medication, because that promise is not ours to make. Whether a plan covers Wegovy or Zepbound is between you, your plan and your pharmacy. Prior authorization is the pharmacy's process and we do not claim to run it, speed it or win it. Some members may use insurance for a drug their plan covers and keep the membership for the clinical relationship. Some are cash-pay at the manufacturers' prices above. Both paths end with the pharmacy billing you directly for the drug.
On HSA and FSA funds, we do not promise the membership fee is eligible. Your account administrator decides that, so check with them before using those funds. The medication itself may be a different question for your administrator and the same caution applies.
Zepbound and Mounjaro are the same molecule, tirzepatide, with different labeled uses. Your clinician explains the choice when a medication is indicated.
What the evidence says about doing this well
The price of the drug is only one side of the value question. The other is whether it works and whether anyone is measuring. The SURMOUNT-1 trial found substantial and sustained weight reductions over 72 weeks on tirzepatide across doses, with individual results varying. STEP 1 showed about 15 percent average weight reduction on semaglutide 2.4 mg over 68 weeks with lifestyle intervention. Those are trial averages and not promises.
The quarterly labs are how a clinician follows the thyroid and fasting insulin markers over time.
Who should pay cash and who should look elsewhere
If your plan covers a branded GLP-1 at a manageable copay, staying insured for the drug is reasonable and the membership can still carry the clinical relationship. If you are cash-pay and your clinician prescribes the Wegovy pill at its lower doses, the manufacturer's published figure is from $149 a month. If you are chasing the lowest price on a compounded vial, we are not the option for you, because we prescribe branded, FDA-approved medication only.
If the structure makes sense, the eligibility check is the first step. It takes a few minutes and a clinician reviews every application. A $598 hold is placed on your card at sign-up and covers the first two months. It is charged only once the clinician accepts you. If the clinician cannot accept you into care, the hold is released and you are never charged. Once accepted, the first two months are charged and non-refundable.
One flat fee for the doctor. Zero markup on the medicine. The pharmacy's price is the pharmacy's business and our fee is the same at any dose.
Frequently Asked Questions
What will my medication cost each month?
Whatever your pharmacy charges. The manufacturers' published self-pay prices as of September 2026 were $199 a month for Wegovy pens for the first two fills, $349 after, from $149 for the Wegovy pill at lower doses and $299 to $449 for Zepbound vials by dose.
Is medication included in the $299 membership?
No. The membership fee covers the clinicians, four cardiometabolic lab panels a year, messaging with the care team and video visits. Medication is a separate charge billed by the pharmacy you choose, at that pharmacy's own price.
Do you take a cut of the pharmacy price?
No. GoodLife Health sets nothing, sees nothing and takes nothing on medication. There is no markup, no molecule upcharge and no dose upcharge.
Will insurance cover my prescription?
It depends on your plan and we never promise coverage. Whether a medication is covered is between you, your plan and your pharmacy. Prior authorization is the pharmacy's process and we do not run it.
Can I use HSA or FSA funds?
We do not promise the membership fee is HSA or FSA eligible. Your account administrator decides, so check with them before using those funds.
What if the price changes?
It may, because manufacturers set those prices and we give them with the date we verified them. The number that does not change is the $299 clinical fee, which is the same whatever is prescribed and whatever the dose.
What if I need a higher dose than the plan anticipated?
Your clinician decides the dose and the fee stays at $299 whatever the dose. If a higher dose is clinically required, the fee still does not change.
How to read a GLP-1 price you see advertised
The advertised numbers come from many places and rarely describe the same thing, so a short decoder helps.
First, separate the drug from the program. Every price in this article so far has been the drug, billed by the pharmacy. A price that includes a subscription, a diet plan or a coaching tier is a bundle. Ask what the drug alone costs and what the rest is.
Second, separate the dose from the drug. A vial price that assumes a low dose tells you almost nothing if your protocol titrates upward, which is why the manufacturers' own price sheets have columns rather than numbers. Read the column your dose is likely to reach, not the one on the banner.
Third, separate the offer from the ongoing. The $199 Wegovy figure is an introductory price for the first two fills. The $349 figure is the ongoing one. Whichever program you evaluate, date both numbers and read both, because the second one is where you will live.
Fourth, ask who earns the spread. If a platform quotes you a bundle and buys the drug at one price while charging you another, the difference is their margin and it grows with your dose. Our structure has no spread to hide. The pharmacy's price is the pharmacy's and the fee is the fee.
Read the dose columns, date the offer and ask who earns the spread. Those three habits price any GLP-1 program more accurately than its advertisement.
One last thing
Before you join anything, write down two numbers. The pharmacy's price for the drug you are likely to be prescribed and the total monthly cost of whatever program you are comparing, read from its dose-escalation column rather than its advertisement. Then compare those against $299 plus the pharmacy price with us. The structure you are buying is the one that never moves.
Related Guides
- The GLP-1 pricing guide: Wegovy, Zepbound, Ozempic
- Cardiometabolic Optimization: the definitive guide
- What a Biomarker Audit includes
- Why we never prescribe compounded GLP-1
References
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). 2022. pubmed.ncbi.nlm.nih.gov/35658024/
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). 2021. pubmed.ncbi.nlm.nih.gov/33567185/